11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Angiotensin-(1-7) inhibits epidermal growth factor receptor transactivation via a Mas receptor-dependent pathway.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The transactivation of the epidermal growth factor (EGF) receptor appears to be an important central transduction mechanism in mediating diabetes-induced vascular dysfunction. Angiotensin-(1-7) [Ang-(1-7)] via its Mas receptor can prevent the development of hyperglycaemia-induced cardiovascular complications. Here, we investigated whether Ang-(1-7) can inhibit hyperglycaemia-induced EGF receptor transactivation and its classical signalling via ERK1/2 and p38 MAPK in vivo and in vitro.

          Related collections

          Author and article information

          Journal
          Br J Pharmacol
          British journal of pharmacology
          Wiley
          1476-5381
          0007-1188
          Mar 2012
          : 165
          : 5
          Affiliations
          [1 ] Department of Pharmacology and Toxicology, Faculty of Medicine, Kuwait University, Safat, Kuwait. saghir@hsc.edu.kw
          Article
          10.1111/j.1476-5381.2011.01613.x
          3372724
          21806601
          a13eff25-8de6-4cb4-b52a-1e1cf0b6c827
          © 2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.
          History

          Comments

          Comment on this article